Oklahoma attorney general fighting to return $2 million stockpile of Trump-touted hydroxychloroquine

Oklahoma attorney general fighting to return $2 million stockpile of Trump-touted hydroxychloroquine
U.S. Air Force 1st Lt. Ian Krug, left, a registered nurse with the 59th Medical Wing, stationed in Lackland Air Force Base, Texas, works with U.S. Air Force Capt. Ramil Labiran, right, a registered nurse with Brooke Army Medical Center, Fort Sam Houston, Texas, and Staff Sgt. LaShauna Brown, center, a medical technician and noncommissioned officer in charge of the pediatric intensive care unit of Walter Reed National Military Medical Center in Bethesda, Md., in a makeshift expansion of the intensive care unit at University Medical Center in El Paso, Texas, Nov. 16, 2020. U.S. Northern Command, through U.S. Army North, remains committed to providing flexible Department of Defense support to the Federal Emergency Management Agency in support of the whole-of-America COVID-19 response. (U.S. Army photo by Sgt. Samantha Hall)
Push Notification

The Oklahoma Attorney General's Office is now seeking to return its $2 million stockpile of hydroxychloroquine, the anti-malarial drug former President Donald Trump touted as an effective form of treatment for COVID-19.

According to The Frontier, back in April, Oklahoma Gov. Kevin Stitt (R) ordered the purchase of 1.2 million hydroxychloroquine pills—equivalent to approximately 100,000 doses—from the California-based, private pharmaceutical wholesale company, FFF Enterprises. On Monday, Jan. 25, Alex Gerszewski, a spokesman for Oklahoma Attorney General Mike Hunter (R), confirmed the office is in negotiations with Oklahoma State Department of Health "to try to figure out a solution," the publication reports.

At the time, the purchase was criticized due to the limited amount of information regarding the effectiveness of the drug as a COVID-19 treatment. However, the state argued that because the drug could be used to treat a multitude of conditions, "that money will not have gone to waste in any respect."

Now, it appears the state is looking to renege on that stance.

With very little evidence to determine whether or not the drug was effective to treat COVID-19, Trump described it as a drug that had "a real chance to be one of the biggest game-changers in the history of medicine," according to Forbes.

The former president also took to Twitter on multiple occasions in an effort to strong-arm the Food and Drug Administration (FDA) into fast-tracking the drug for emergency use despite public health experts warning against doing so. Multiple studies also deemed the drug ineffective for treating COVID-19.

At the time, Dr. Anthony Fauci also pushed back against Trump's claims. During an appearance on "Good Morning America," Fauci told ABC News' Chief Anchor George Stephanopoulos, "The overwhelming, prevailing clinical trials that have looked at the efficacy of hydroxychloroquine have indicated that it is not effective in coronavirus disease."

Understand the importance of honest news ?

So do we.

The past year has been the most arduous of our lives. The Covid-19 pandemic continues to be catastrophic not only to our health - mental and physical - but also to the stability of millions of people. For all of us independent news organizations, it’s no exception.

We’ve covered everything thrown at us this past year and will continue to do so with your support. We’ve always understood the importance of calling out corruption, regardless of political affiliation.

We need your support in this difficult time. Every reader contribution, no matter the amount, makes a difference in allowing our newsroom to bring you the stories that matter, at a time when being informed is more important than ever. Invest with us.

Make a one-time contribution to Alternet All Access, or click here to become a subscriber. Thank you.

Click to donate by check.

DonateDonate by credit card
Donate by Paypal
{{ post.roar_specific_data.api_data.analytics }}
@2022 - AlterNet Media Inc. All Rights Reserved. - "Poynter" fonts provided by fontsempire.com.